Vnitr Lek 2009, 55(9):738-745

Transplantation of haematopoietic cells

M. Krejčí*, J. Mayer, Z. Adam, J. Vorlíček
Interní hematoonkologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jiří Vorlíček, CSc.

Autologous and allogeneic transplantations of haematopoietic cells form an important part of treatment of, particularly haematological, malignancies but have their place in the treatment of other diseases as well. Transplantation brings permanent remission in a number of patients. However, transplantation, and the allogeneic one in particular, is associated with a range of complications. The following review paper provides information on the types of transplants, their collection and processing, on the options for and ways to seek suitable donors of haematopoietic cells. Other sections of the paper focus on preparatory pre-transplantation regimens and complications that might occur after the transplantation. Finally, the paper reviews clinical uses of haematopoietic cell transplantations and provides a summary of diagnoses in which this treatment method can be applied.

Keywords: autologous transplantation; allogeneic transplantation; haematopoietic cells

Received: July 15, 2009; Published: September 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krejčí M, Mayer J, Adam Z, Vorlíček J. Transplantation of haematopoietic cells. Vnitr Lek. 2009;55(9):738-745.
Download citation

References

  1. Basara N, Kiehl MG, Fauser AA. New therapeutic modalities in the treatment of graft-versus-host disease. Crit Rew Oncol Hematol 2001; 38: 129-138. Go to original source... Go to PubMed...
  2. Faber E. Transplantace krvetvorných buněk. In: Indrák K et al (eds). Hematologie. Praha: Triton 2006: 237-247.
  3. Filipovich AH, Weisdorf D, Pavletic S et al. National institute of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956. Go to original source... Go to PubMed...
  4. Grathwohl A, Baldomero H, Fauendorfer K et al. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow Transplant 2007; 39: 71-87. Go to original source... Go to PubMed...
  5. Ljungman P, Urbano-Ispizua A, Cavazzana-Calvo M et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2006; 37: 439-449. Go to original source... Go to PubMed...
  6. Mayer J, Cetkovský P, Krejčí M. Steroid-rezistentní akutní reakce štěpu proti hostiteli. Transfuze Hematol dnes 2007; 13: 192-199.
  7. Mayer J, Starý J. Vysokodávkovaná chemoterapie a transplantace krvetvorných buněk. In: Mayer J et al (eds). Leukemie. Praha: Grada Publishing 2002: 196-212.
  8. Mayer J. Co jsou nemyeloablativní transplantace krvetvorných buněk? Vnitř Lék 2001; 47 (Suppl 1): 29-33. Go to PubMed...
  9. Przepiorka D, Weisdorf D, Martin P et al. Consensus conference on acute GVHD grading. Bone Marow Transplant 1995; 15: 825-828.
  10. Sullivan KM. Graft versus host disease. In: Thomas ED, Blume KG, Forman SJ et al (eds). Hematopoietic Cell Transplantation. Oxford: Blackwell Science 1999: 515-536.
  11. Vaňásek J, Starý J, Kavan P et al. Transplantace kostní dřeně. Praha: Galén 1996.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.